RetiNova Therapeutics
Pre-clinicalREGENERATIVE THERAPY FOR RETINAL DISEASE
Founded
2021
Focus
Biologics
About
REGENERATIVE THERAPY FOR RETINAL DISEASE
Funding History
2Total raised: $25M
Series A$20MUndisclosedMar 15, 2022
Seed$5MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile